Drug Type Oncolytic bacteria |
Synonyms AUP 55, AUP-5550 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bladder Cancer | Preclinical | Finland | 01 Oct 2025 | |
| Melanoma recurrent | Preclinical | Switzerland | 01 Oct 2024 | |
| Ovarian Cancer | Preclinical | Finland | - | |
| Peritoneal Neoplasms | Preclinical | Finland | - |





